Aerovate Therapeutics (AVTE) Q3 2023 Earnings

Nov 13Confirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.71
-0.47
-0.24
0

Details

Expected EPS
-0.69
Actual EPS
-0.71
Surprise EPS
-0.02
Surprise Percent
-2.9%

Description

⁨Aerovate Therapeutics⁩ (⁦AVTE⁩) has reported earnings of ⁦-0.71⁩ per share for ⁦Q3 2023⁩.

0 Comments

Share your thoughts